Form CT ORDER - Confidential treatment order:
SEC Accession No. 9999999997-18-009595
Filing Date
2018-12-17
Accepted
2018-12-17 17:01:14
Documents
1

Document Format Files

Seq Description Document Type Size
1 filename1.pdf CT ORDER 76643
  Complete submission text file 9999999997-18-009595.txt   106797
Mailing Address 4505 EMPEROR BOULEVARD SUITE 200 DURHAM NC 27703
Business Address 4505 EMPEROR BOULEVARD SUITE 200 DURHAM NC 27703 919-859-1302
BIOCRYST PHARMACEUTICALS INC (Filer) CIK: 0000882796 (see all company filings)

EIN.: 621413174 | State of Incorp.: DE | Fiscal Year End: 1231
Type: CT ORDER | Act: 34 | File No.: 000-23186 | Film No.: 181238685
SIC: 2836 Biological Products, (No Diagnostic Substances)